PREservation Versus Thermal Ablation
PRETA
1 other identifier
observational
150
1 country
1
Brief Summary
This study will be looking at the effect of Ambulatory Selective Varices Ablation under Local Anesthesia (ASVAL) and Endovenous Laser Ablation (EVLA) with concomitant phlebectomy in patients with incompetent great saphenous vein (GSV).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 23, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 23, 2019
CompletedFirst Posted
Study publicly available on registry
July 26, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2025
CompletedFebruary 10, 2023
February 1, 2023
6.6 years
July 23, 2019
February 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Number of Participants with pain or other discomfort (ie aching, heaviness, fatigue, soreness, burning) from absent (score 0) to severe (score 3)
None (0), Occasional (1), Daily, interfering with, but not preventing regular daily activities (2), Daily limiting most regular daily activities (3)
2-5 years
Number of Participants with varicose Veins from absent (score 0) to severe (score 3).
None (0), Few, scattered (1), Confined to calf or thigh (2) Involve calf and thigh (3)
2-5 years
Number of Participants with venous oedema from absent (score 0) to severe (score 3).
None (0) Limited to foot or ankle (1), Extends above ankle but below knee (2), Extends to knee or above (3)
2-5 years
Number of Participants with skin Pigmentation from absent (score 0) to severe (score 3).
None (0), Limited to perimalleolar area (1), Diffuse over lower third of calf (2), Wider distribution (above lower third of calf) (3)
2-5 years
Number of Participants with inflammation from absent (score 0) to severe (score 3).
None (0), Limited to perimalleolar area (1), Diffuse over lower third of calf (2), Wider distribution (above lower third of calf) (3)
2-5 years
Number of Participants with induration from absent (score 0) to severe (score 3).
None (0), Limited to perimalleolar area (1), Involving lower third of calf (2), Involving more than lower third of calf (3)
2-5 years
Number of Participants with active ulcers from absent (score 0) to severe (score 3).
None (0), 1 (1), 2 (2), more than 2 (3)
2-5 years
Number of Participants with different duration of active ulcer: from absent (score 0) to severe (score 3).
None (0), Less than 3 months (1), More than 3 months but less than 1 year (2) More than 1year (3)
2-5 years
Number of Participants with active ulcer diameter from absent (score 0) to severe (score 3).
None (0), Diameter less than 2 cm (1), Diameter 2-6 cm (2), Diameter more than 6 cm (3)
2-5 years
Number of Participants with compression therapy from absent (score 0) to severe (score 3).
Not used (0), Intermittent use of stockings (1), Uses stockings most days (2), Full compliance with stockings (3)
2-5 years
Secondary Outcomes (1)
Number of Participants with clinical recurrence-free rate (no - score 0, yes - score 1)
2-5 years
Study Arms (2)
ASVAL - group
GSV diameter ≤ 6 mm
EVLA-group
GSV diameter \> 6 mm
Interventions
Eligibility Criteria
Patients with GSV incompetence and C2-C3 were included in the prospective consecutive case study if they satisfied the selection criteria
You may qualify if:
- Great saphenous vein (GSV) incompetence with reflux at least down to the knee level
- Primary symptomatic varicose veins, Clinical Etiological Anatomical Pathophysiological (CEAP) classification, clinical class C2-C3
- Physical status according to American Society of Anesthesiologists (ASA) I-II (I-Healthy, non-smoking, no or minimal alcohol use; II-Mild diseases only without substantive functional limitations)
You may not qualify if:
- Previous surgical groin exploration, except herniotomy
- Small saphenous vein, anterior or posterior accessory saphenous vein incompetence at the same limb
- Deep venous thrombosis, thrombophilia associated with a high risk of deep venous thrombosis or postthrombotic syndrome
- Arterial occlusive disease more severe than Intermittent claudication after more than 200 meters of pain free walking (Fontaine IIA) and/or ankle brachial index below 0.8
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Educational Institution"Belarusian State Medical University"
Minsk, Dzerzhinski Ave., 83, 220116, Belarus
Related Publications (7)
Pittaluga P, Chastanet S. Persistent incompetent truncal veins should not be treated immediately. Phlebology. 2015 Mar;30(1 Suppl):98-106. doi: 10.1177/0268355515569141.
PMID: 25729076BACKGROUNDChastanet S, Pittaluga P. Influence of the competence of the sapheno-femoral junction on the mode of treatment of varicose veins by surgery. Phlebology. 2014 May;29(1 suppl):61-65. doi: 10.1177/0268355514529207. Epub 2014 May 19.
PMID: 24843088BACKGROUNDvan Neer P, Kessels FG, Estourgie RJ, de Haan EF, Neumann MA, Veraart JC. Persistent reflux below the knee after stripping of the great saphenous vein. J Vasc Surg. 2009 Oct;50(4):831-4. doi: 10.1016/j.jvs.2009.05.021. Epub 2009 Jul 12.
PMID: 19595549BACKGROUNDZolotukhin IA, Seliverstov EI, Zakharova EA, Kirienko AI. Short-term results of isolated phlebectomy with preservation of incompetent great saphenous vein (ASVAL procedure) in primary varicose veins disease. Phlebology. 2017 Oct;32(9):601-607. doi: 10.1177/0268355516674415. Epub 2016 Oct 19.
PMID: 27760806BACKGROUNDHarlander-Locke M, Jimenez JC, Lawrence PF, Derubertis BG, Rigberg DA, Gelabert HA. Endovenous ablation with concomitant phlebectomy is a safe and effective method of treatment for symptomatic patients with axial reflux and large incompetent tributaries. J Vasc Surg. 2013 Jul;58(1):166-72. doi: 10.1016/j.jvs.2012.12.054. Epub 2013 Apr 6.
PMID: 23571079BACKGROUNDPuggioni A, Kalra M, Carmo M, Mozes G, Gloviczki P. Endovenous laser therapy and radiofrequency ablation of the great saphenous vein: analysis of early efficacy and complications. J Vasc Surg. 2005 Sep;42(3):488-93. doi: 10.1016/j.jvs.2005.05.014.
PMID: 16171593BACKGROUNDNesbitt C, Bedenis R, Bhattacharya V, Stansby G. Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus open surgery for great saphenous vein varices. Cochrane Database Syst Rev. 2014 Jul 30;(7):CD005624. doi: 10.1002/14651858.CD005624.pub3.
PMID: 25075589BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Genadz Kandratsenka, Prof
Educational Institution"Belarusian State Medical University"
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 23, 2019
First Posted
July 26, 2019
Study Start
January 1, 2013
Primary Completion
July 23, 2019
Study Completion
February 1, 2025
Last Updated
February 10, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- 01.2020
- Access Criteria
- To compare clinical efficacy of Ambulatory Selective Varices Ablation under Local Anesthesia (ASVAL) and Endovenous Laser Ablation (EVLA) with concomitant phlebectomy in patients with incompetent great saphenous vein (GSV).
To compare clinical efficacy of Ambulatory Selective Varices Ablation under Local Anesthesia (ASVAL) and Endovenous Laser Ablation (EVLA) with concomitant phlebectomy in patients with incompetent great saphenous vein (GSV).